SAVE THE DATE: Immunity for Health 2018

Flanders Vaccine

On October 11th 2018 Flanders Vaccine is happy to host its third edition of “Immunity for Health”: the Flanders Vaccine annual flagship event where all stakeholders, both from the human and animal health sector, working in the field of immunology, vaccinology, immune-oncology and infectious diseases are invited to meet, interact and start collaborations.

The theme of this year’s edition is “Preventive Health Care“. We are honoured to welcome some renowned experts in the field and are looking forward to be inspired by their talks!

Location: Leuven, Belgium


08:30 REGISTRATION and welcome coffee
09:30 OPENING KEYNOTE I :  topic “How can vaccines and immunotherapeutics support preventive healthcare – Preventing infections, preventing the spread of resistance”
Paul Stoffels, Executive Vice President, Chief Scientific Officer, Johnson & Johnson (tbc)

Part I: Clinical Trials Track – Preventive healthcare in Belgium
Chair: tbc

10:00 KEYNOTE II :  topic “ Preventive healthcare policy: How can we stimulate participation in clinical trials”
Representative of Ministry of Social Affairs and Public Health


11:00 Talk I:  topic: “Polio vaccine study”
Pierre Van Damme, Professor University of Antwerp and member of the board of Flanders Vaccine

11:20 Talk II: topic “Strengths of the Flemish Vaccination policy”
Geert Top, Agentschap Zorg & Gezondheid & Corinne Vandermeulen, professor KU Leuven and member of the board of Flanders Vaccine

11:40 Pitch: 3 x 12 min

12:20 LUNCH

Part II: R&D – Preventive healthcare for sustainable use of AB
Chair: SGS (event sponsorship)

13:20 KEYNOTE III: topic “AB resistance in human and veterinary medicine: critical molecules and bacteria and how (novel) vaccines can help”
Herman Goosens, professor University of Antwerp

13:50 Talk III:  topic “ Vaccines as (part of) the solution towards sustainable use of AB”
Speaker to be confirmed

14:10 Talk IV: topic “ Modulate immunity to increase host defense as (part of) the solution towards sustainable use of AB”
Speaker to be confirmed

14:30 Talk V: topic “Update on the pig model for vaccine R&D (One Health)”
Hugo Van Heuverswyn, CEO Biomaric

14:40 Pitch: 2 x 12 min


Part III: track Regional and international visibility
Chair: tbc

 15:30 Talk VI: topic “collaboration Flanders Vaccine and Immuno Valley (The Netherlands)”
Speaker to be confirmed

15:50 Talk VII: topic “collaboration Flanders Vaccine and BioWin (Wallonia)”
Speaker to be confirmed

16:10 CLOSING KEYNOTE :  gold sponsor

16:40 Awareness via Media (tbc)
17:00 Network reception